Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T14:10:31.801Z.
Calculation as of: 2026-10-06T14:10:31.801Z.
Quote observation: 2026-10-06T14:08:31.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 017b786e338061c10a4665063360519c0b30ae95494f37f63af909a19a8b52dc
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Market Cap
$55.94M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Adicet Bio, Inc. (ACET) | $59.97M | N/A | N/A | N/A | N/A |
| MiNK Therapeutics, Inc. (INKT)vs › | $59.51M | N/A | N/A | N/A | N/A |
| Aldeyra The (ALDX)vs › | $58.83M | N/A | N/A | N/A | N/A |
| Fractyl Health, Inc. (GUTS)vs › | $58.97M | N/A | N/A | N/A | N/A |
| Boundless Bio, Inc. (BOLD)vs › | $58.66M | N/A | N/A | N/A | N/A |
| Spectral AI, Inc. (MDAI)vs › | $57.33M | N/A | N/A | N/A | N/A |
| InterCure Ltd. (INCR)vs › | $62.78M | N/A | 9.73x | 23.03x | 21.55x |
| Connect Biopharma Holdings Limited (CNTB)vs › | $55.94M | N/A | N/A | N/A | N/A |
| Kalaris Therapeutics Inc (KLRS)vs › | $63.95M | N/A | N/A | N/A | N/A |
| Alps Group Inc (ALPS)vs › | $64.06M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
